CERT · Earnings event · Q2 2026 · archived
Certara (CERT) Q2 2026 earnings — TrendMatrix coverage
Reported · EPS $0.08 vs estimate $0.09 (-12.2%) — classified INLINE.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Event detail · Q2 2026
EPS beat/miss and revenue
| Metric | Estimate | Actual | Surprise |
|---|---|---|---|
| EPS (diluted) | $0.09 | $0.08 | -12.2% |
| Revenue (2026-06-30) | — | $93.3M | — |
Revenue source: xbrl.
Verdict reaction
How the verdict moved around this report
Before this report, TrendMatrix rated CERT Hold at 4.7/10. After the Q2 2026 report, the verdict moved to Sell at 4.8/10.
Healthcare context
CERT at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Health Information Services
- Market cap
- $1.22B
- P/E (fwd)
- 20.3
- 52-week range
- $4.45–$13.88
- Off 52-week high
- 42.5%
- RSI (14)
- 55
- Volume vs avg
- 0.36×
- Engine score
- 4.5/10
Live context at TrendMatrix’s latest engine read — updates after the report date; not frozen to it.